In recent years there has been increased awareness and diagnosis of food allergy. In addition, it has become apparent that patients may become sensitized to multiple foods which share homologous proteins and that this may lead to serious clinical problems. It has long been known that there are cross-reactions between di¡erent allergens e.g. people with latex allergy often experience allergy to bananas and kiwi fruit.
As more food allergies are diagnosed and the agents responsible identi¢ed, the number of allergens known to be involved in cross-sensitization grows.
The diagnosis of food allergy is generally made using a careful history and physical examination along with one or more investigations such as skin prick testing, allergen-speci¢c IgE testing (RASTs), food challenges, etc. Identifying the causal food allergen may be complicated by cross-reactivity with other plant or animal proteins. Some cross-reactive allergens may not be apparent clinically but may be revealed by a positive RAST test^leading to the question, is the patient likely to have a signi¢cant allergic reaction to these cross-reactive allergens in the future?
It is fairly well known that individuals with an allergy to a legume (e.g. peanuts) are more likely to have high speci¢c IgE responses to other legumes, even though it is unusual for patients to experience an allergic reaction to the other legumes.
Among tree nut allergies, however, there is a high degree of cross-sensitization and corresponding clinical response^patients known to be allergic to one tree nut often report an allergic response (often severe) to other tree nuts, and this is borne out by the results of RAST testing.
Latex allergy is increasingly recognized, particularly among health care workers. Its evaluation is complicated by cross-reacting pollens and foods. Common cross-reacting allergens include kiwi fruit and bananas. In 136 patients with latex allergy evaluated with RASTs to 12 commonly cross-reacting foods, 69% were positive for at least one food. Oral challenges were not performed but only one-third of patients with positive responses gave a clinical history of reactions to the implicated food.
In clinical use, the evaluation of RAST results is di¤-cult and compounded by frequent false positives. In this situation, performing a battery of RASTs is likely to increase diagnostic confusion. A negative result is of value in concluding that a clinical response to the allergen is unlikely. The results of skin-prick tests are confounded by issues surrounding the commercial extracts used. Where commercial extracts are not available, the fresh food may be used directly but there may be signi¢cant allergenic di¡erences between di¡erent batches of the food, or between the food in its raw and cooked state.
The oral challenge remains the only means of identifying true clinical reactions, although potentially severe reactions are possible. In practice, many patients maintain a diet derived from their clinical history, the available literature and results of RASTs and skin prick tests. The inputs of an experienced clinician and dietician, however, are required to avoid the dangers of unnecessarily excluding food groups from the diet.
As awareness of food allergies and their investigation continues to increase, the ¢nding of crossreactivity either in vitro or in vivo is likely to continue to cause confusion in an already uncertain area. The authors examined the incidence of immunoassay interference in 5312 new patients submitted for CEA measurement at the central laboratory in Oslo, Norway, over a period of 10 months. The study targeted CEA measurement because it is a convenient and stable tumour marker, levels of which are low in`unaffected' individuals (<50 mg/L). The central laboratory used an in-house, two-site, two-step immunometric assay format. In this assay, whole murine monoclonal antibodies were used. The aim of the study was to ¢nd samples with interference severe enough to prompt a di¡erent clinical interpretation of the results.
Interference was studied by re-analysing samples following a number of modi¢ed procedures, namely, adding di¡erent reagents to their assay cocktail and using antibody fragments, rather than the whole monoclonal antibody, as reagent. Reagents added individually were: non-immune, non-speci¢c murine Ig (native MAK 33, Roche Molecular Biochemicals); heat-treated (i.e. aggregated) MAK 33; and F(ab) 2 fragment (prepared by removing the Fc region from the monoclonal antibodies). A modi¢ed assay format using F(ab) 2 fragment plus heat-treated MAK 33 was best for reducing immunoassay interference and was therefore regarded as a`reference assay'. Interference was considered to be present when the routine assay had an apparent CEA result above the reference limit of 5 mg/L and had a 60% higher result than the`reference assay'. The authors report a 4% level of interference in the routine assay used by the central laboratory. The simple addition of native MAK 33 (i.e. non-immune murine Ig) had very little e¡ect on reducing interference (3.9%). However, heat-treated MAK33 signi¢-cantly reduced interference by 79%. The amount added appeared to be critical, since increasing concentration threefold further reduced interference from 79 to 99%. Simple removal of the Fc region and the use of F(ab) 2 fragment by itself reduced interference by 98%.
The study is of general interest in highlighting the frequency of interference leading to gross inaccuracy and potential misinterpretation of results. The addition of native MAK 33 (i.e. non-immune murine Ig) which is supposed to block`HAMA' was ine¡ective. However, F(ab) 2 fragments and/or heat-treated MAK 33 were highly e¡ective in reducing interference, although interference persisted in two cases and was established only following serial dilution. Furthermore, these manoeuvres may not be applicable to other assays. However, this paper helps to illustrate the di¤cult and intrinsic problem of inaccuracy of some immunoassay results.
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